Prevention of Wound Complications After Cesarean Delivery in Obese Women Utilizing Negative Pressure Wound Therapy
NCT ID: NCT00654641
Last Updated: 2013-01-30
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
54 participants
INTERVENTIONAL
2007-09-30
2010-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Women will be randomly selected to receive standard stitching and stapling of the incision (cut on the abdomen) or closure with stitches, staples and wound suction. Subjects will be seen for follow-up visits in 7-14 days and again at 4-6 weeks after surgery. The number of wound complications in each group will be compared. If the wound suction technique is successful in preventing wound complications, this may substantially reduce pain and suffering in a large number of women undergoing C-section for delivery.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vacuum Assisted Closure for Cesarean Section
NCT02390401
Negative Pressure Wound Therapy to Prevent Wound Complications Following Cesarean Section in High Risk Patients
NCT03082664
Prophylactic Incisional Care in Obese Women at Cesarean
NCT02578745
The Effect of Forced Air Warming During Cesarean Section on Postoperative Infectious Morbidity
NCT00696462
A Comparison of Incisional Negative-Pressure Wound Therapy Versus Conventional Dressings Following Abdominal Surgery
NCT02534116
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Negative pressure wound closure
Negative Pressure wound closure
Negative pressure wound closure
Applying negative pressure to primary wound closure
Standard wound closure
Standard Wound Closure
Standard wound closure
Standard wound closure
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Negative pressure wound closure
Applying negative pressure to primary wound closure
Standard wound closure
Standard wound closure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patient at least 18 years of age.
3. Weight greater than 199 pounds.
4. Depth of subcutaneous tissue (measured from fascia to epidermis) of greater than or equal to 4 centimeters.
Exclusion Criteria
2. Inability to give proper informed consent.
3. Inability to adhere to follow-up provisions of the study (return for 2 post-operative visits at 7-14 days post-op and between 4-6 weeks post-op).
4. Patient less than 18 years of age.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CAMC Health System
OTHER
West Virginia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael Stitely
Adjunct Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael L Stitely, MD
Role: PRINCIPAL_INVESTIGATOR
West Virginia University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CAMC Women and Children's Hospital
Charleston, West Virginia, United States
West Virginia University
Morgantown, West Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-20292
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.